Programs

  • RET-Positive Cancer Awareness Project

    Program Service Accomplishment #1: Raise Awareness -- In 2023 RETpositive focused on raising awareness about RET-positive cancers. The organization produced an inspirational "Hope Video," featuring RET-positive cancer survivors to educate the public and healthcare professionals. The project involved on-site filming in Boston Massachusetts and covered travel expenses for participating survivors. The total expenditure for this project was approximately $35,000. The video was widely distributed in 2024 across various platforms to enhance understanding and support for individuals affected by RET-positive cancers.
    Geographies
    Not indicated
    Dates
    Jan 1, 2023 – Dec 31, 2023
    Source
    990
    No causes provided
    No populations provided
    –
    $35K

  • Community Support and Advocacy for RET-Positive Patients

    Program Service Accomplishment #2: Provide Community Support & Advocacy -- Throughout 2023 RETpositive provided ongoing community support and advocacy entirely on a volunteer basis. Activities included moderating social media discussions organizing virtual meetups and partnering with organizations like Lungevity and Happy Lungs to promote meaningful advocacy and legislation awareness. These efforts aimed to foster a supportive community for RET-positive cancer patients and their caregivers.
    Geographies
    Not indicated
    Dates
    Jan 1, 2023 – Dec 31, 2023
    Source
    990
    No causes provided
    No populations provided
    –
    $0

  • Medical Research Promotion for RET-Positive Cancers

    Program Service Accomplishment #3: Promote Medical Research -- In 2023 RETpositive actively updated its clinical trials opportunities page as a resource for patients and continued to review and support research initiatives in collaboration with organizations like Lungevity and Hamoui. While no expenses were incurred in 2023 the organization engaged in fundraising efforts to issue a new research grant in 2024 aiming to advance medical research pertinent to RET-positive cancers.
    Geographies
    Not indicated
    Dates
    Jan 1, 2023 – Dec 31, 2023
    Source
    990
    No causes provided
    No populations provided
    –
    $0